COVID-19 Impact on Exoskeleton Market
New York, May 30, 2020: You will get latest updated report as per the COVID-19 Impact
on this industry. Our updated reports will now feature detailed analysis that will help you
make critical decisions.
The report covers detailed competitive outlook including the market share and company
profiles of the key participants operating in the global market. Key players profiled in the
report include Myomo (NYSEAMERICAN: MYO), Ekso Bionics (NASDAQ :EKSO), Rex Bionics
Plc, Cyberdyne, Inc., ReWalk Robotics Ltd. (NASDAQ: RWLK), Lockheed Martin Corporation,
Suit X (U.S. Bionics Inc.), RB3D, and Hocoma. Company profile includes assign such as
company summary, financial summary, business strategy and planning, SWOT analysis and
The Exoskeleton Market is expected to be around US$ 3 Billion by 2025 at a CAGR of 24%
in the given forecast period.
Browse Full Report Here: https://www.marketresearchengine.com/exoskeleton-
An exoskeleton is that the external skeleton that supports and protects an animal's body, in
contrast to the interior skeleton (endoskeleton) of, for instance, a human. In usage, a
number of the larger varieties of exoskeletons are called "shells".
The Exoskeleton Market is segmented on the lines of its end-user, technology, Stationary
Technology and regional. Based on end-user it covers HealthCare, Military and Industrial.
Basis of Stationary Technology is segmented into active and passive. Based on technology it
covers Mobile Exoskeleton and Stationary Exoskeleton. The Exoskeleton Market on
geographic segmentation covers various regions such as North America, Europe, Asia
Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented
to provide market revenue for select countries such as the U.S., Canada, U.K. Germany,
China, Japan, India, Brazil, and GCC countries.
The Exoskeleton Market has been segmented as below:
The Exoskeleton Market is segmented on the Basis of End-User Type, St